Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
2010

Genomic and Epigenomic Instability in Schizophrenia and Autism

publication Evidence: moderate

Author Information

Author(s): Smith Cassandra L., Bolton Andrew, Nguyen Giang

Primary Institution: Boston University

Hypothesis

Is there a link between genomic and epigenomic instability and neuropsychiatric diseases like schizophrenia and autism?

Conclusion

The study suggests that genomic and epigenomic instability, particularly involving fragile sites, is associated with schizophrenia and autism.

Supporting Evidence

  • Genomic instability is linked to neuropsychiatric diseases.
  • Fragile sites are regions of the genome prone to mutation.
  • Schizophrenia and autism share genetic and environmental risk factors.

Takeaway

This study looks at how changes in our genes and their regulation might be connected to mental health issues like schizophrenia and autism.

Methodology

The article reviews existing studies linking genomic instability and fragile sites to schizophrenia and autism.

Limitations

The research is primarily based on existing literature and may not include new experimental data.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2174/138920210793176001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication